Amylyx Pharmaceuticals Investor Lawsuit: Overstated Drug Potential?
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
- Latest
- Trending
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
GitLab Inc. (NASDAQ: GTLB) is set to announce its Q4 and year-end financial results, with expectations of strong growth and ...
Arm's stock price has soared as investors chase opportunities in the AI sector. Despite concerns about valuation, the rally suggests ...
Stock futures dip as investors await inflation report release. ZoomInfo beats expectations, Arista Networks and Cadence Design Systems decline. S&P ...
Medical technology company TransMedics Group, Inc. is set to release its Q4 and full year 2023 financial results, highlighting its ...
Safehold Inc. reports positive financial results for Q4 and FY2023, with increased revenue, adjusted net income, and an upgraded credit ...
Shares of industrial & transportation companies rise as optimism grows over economic outlook. Michelin plans share repurchase. Digital freight broker ...
AllianceBernstein reports marginal increase in AUM for January 2024, due to market gains and net outflows. Retail channel sees net ...
Optex Systems Holdings, Inc. reports impressive surge in revenue and profit for Q4 2023, with total revenues up 72.5% and ...
Energy Services of America Corporation has reported impressive Q4 2023 results with a surge in revenue and earnings. Despite a ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.